NCT00002458View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1987

Primary Completion Date

September 30, 2001

Study Completion Date

September 30, 2001

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

monoclonal antibody 3F8

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002458 - Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission | Biotech Hunter | Biotech Hunter